Image ©Eric Snyder, Huntsman Cancer Institute. Photo shows lung cancer driven by the ightutant Kras gene. Mutations in Kras drive many types of cancer, and researchers are working to develop treatments that target cancers associated with these genetic alterations.

Live video and archive links

• Thursday, December 1, 2016 morning session »
• Thursday, December 1, 2016 afternoon session »
• Friday, December 2, 2016 morning session »

S.J. Quinney College of Law Moot Courtroom, Level 6
The federal Precision Medicine Initiative (PMI) announced in 2015 will be the largest study of human genetics and health in history. With a planned cohort of one million Americans, the PMI promises to increase our understanding of the genetic basis of disease and forge the way for new diagnostic and therapeutic innovations. The PMI is linked to another ambitious national initiative, Vice President Joe Biden’s “Cancer Moonshot,” which hopes to accelerate the cure for cancer using big data and precision oncology techniques.  Though the technology to undertake these monumental projects exists today, many scientific, legal, economic, and ethical questions remain. This one and a half day symposium at the University of Utah will host leading national experts in medicine, bioinformatics, law, policy and ethics who are tackling the major questions raised by precision medicine, the PMI, and the Cancer Moonshot.

#precisionmedicine #UUPrecMed

Proceedings »

Listen to Emily Coonrod and Jorge Contreras discuss issues facing precision medicine »

Sponsored by the University of Utah S.J. Quinney College of Law’s Center for Law and Biomedical Sciences, University of Utah Health Sciences, Huntsman Cancer Institute, and University of Utah Center for Excellence in ELSI Research (UCEER).

Registration is now closed for this event

View the 2015 Precision Medicine Archive »

Precision Medicine Symposium 2015 – Conference Proceedings »

Keynote by Dr. Christopher Austin, Director, National Center for Advancing Translational Science (NCATS)

 

Symposium Agenda

December 1, 2016
9:00 a.m. – 5:30 p.m. , S.J. Quinney College of Law, Level 6

9:00-9:10 a.m. – Welcome
9:10-9:30 a.m. – Opening Remarks

• Willard Dere, M.D., University of Utah

Session 1: Tackling Cancer with Precision Data
This session will explore current approaches to clinical precision oncology and the practical aspects of utilizing the large data sets generated in precision oncology for patient care.

This activity has been approved for AMA PRA Category 1 Credit^TM.

The Science of Precision Oncology (9:30-10:30 a.m.)
Moderated by Ana Maria Lopez, M.D., M.P.H., University of Utah

• Kathleen Cooney, M.D., University of Utah
• Scott Tomlins, M.D., University of Michigan

The Challenges of Big Data (10:40-11:40 a.m.)
Moderated by Kensaku Kawamoto, M.H.S., M.D., Ph.D., University of Utah

• David Nix, Ph.D, Huntsman Cancer Institute
• Samir Courdy, MBA, Huntsman Cancer Institute
• Rakesh Nagarajan, M.D., Ph.D., Washington University in St. Louis, PierianDx

Session 2: Precision Prevention (11:50-12:40 p.m.)
Current techniques for cancer prevention based on genetic information will be discussed, specifically in the context of colorectal and lung cancers. Moderated by Cornelia Ulrich, M.S., Ph.D., University of Utah

This activity has been approved for AMA PRA Category 1 Credit^TM.

• Ulrike Peters, M.P.H., Ph.D., M.S., University of Washington, Fred Hutchinson Cancer Research Center
• Marc Lenburg, Ph.D., Boston University School of Medicine

Lunch (12:40-1:20 p.m.)

Keynote Speaker (1:20-2:00 p.m.)
Catalyzing Translational Innovation
Christopher Austin, M.D., National Center for Advancing Translational Sciences
Introduction by Willard Dere, M.D., University of Utah

This activity has been approved for AMA PRA Category 1 Credit^TM.

Session 3: The Public and Precision Medicine
Strategies for recruiting and engaging the public in large cohort research studies while also ensuring that precision medicine approaches are accessible to underserved populations will be presented.

Recruiting Large Research Cohorts (2:10-3:10 p.m.)
Moderated by James Tabery, Ph.D, University of Utah

• Laurence Meyer, M.D., Ph.D., Veterans Administration Medical Center
• Catherine Schaefer, Ph.D., Kaiser Permanente Division of Research

Engaging the Public in the Program (3:20-4:20 p.m.)
Moderated by Jeffrey Botkin, M.D., M.P.H., University of Utah

• Angela Fagerlin, Ph.D., University of Utah
• Kimberly Kaphingst, Sc.D., University of Utah

The Ethics of Access and Precision Medicine (4:30-5:30 p.m.)
Moderated by Leslie Francis, J.D., Ph.D., University of Utah

• Jessica Roberts, J.D., University of Houston Law Center
• Maya Sabatello, Ph.D., Columbia University College of Physicians and Surgeons

December 2, 2016
9:00 a.m. – 1:00 p.m.,  S.J. Quinney College of Law, Level 6

Session 4: Patenting Precision Medicine (9:00-10:20 a.m.)
How current legal trends limiting the patentability of precision medicine discoveries and techniques may affect their development, availability and quality. Moderated by Jorge Contreras, J.D., University of Utah

• Bernard Chao, J.D., University of Denver
• Colleen Chien, J.D., Santa Clara University
• Shubha Ghosh, J.D., Ph.D., Syracuse University
• Kshitij Kumar Singh, Ph.D., Amity Institute of Advanced Legal Studies

Session 5: Providers, Payers, and Laboratory Testing (10:30 a.m.-12:00 p.m.)
Issues of cost-effectiveness, insurance reimbursement, and the practice of precision oncology in laboratory medicine will be presented. Moderated by Allie Grossmann, M.D., Ph.D., University of Utah

This activity has been approved for AMA PRA Category 1 Credit^TM.

• Diana Brixner, R.Ph., Ph.D., University of Utah
• Christopher Corless, M.D., Ph.D., Oregon Health & Science University
• Craig Nichols, M.D., Intermountain Healthcare

Concluding Remarks

• Willard Dere, M.D.
• Jorge Contreras, J.D

 

Lunch & Adjourn (12:15-1:00 p.m.)

 

2 CLE (including 1 ethics) credit hours (pending). (See below for CME credit)

Accreditation: The University Of Utah School Of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA Credit: The University of Utah School of Medicine designates this live activity for a maximum of 6.00 AMA PRA Category 1 Credit(s)™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nondiscrimination and Disability Accommodation Statement: The University of Utah does not exclude, deny benefits to or otherwise discriminate against any person on the basis of race, color, national origin, sex, disability, age, veteran’s status, religion, gender identity/expression, genetic information, or sexual orientation in admission to or participation in its programs and activities.  Reasonable accommodations will be provided to qualified individuals with disabilities upon request, with reasonable notice.  Requests for accommodations or inquiries or complaints about University nondiscrimination and disability/access policies may be directed to the Director, OEO/AA, Title IX/Section 504/ADA Coordinator, 201 S President’s Circle, RM 135, Salt Lake City, UT 84112, 801-581-8365 (Voice/TTY), 801-585-5746 (Fax).

For questions about this event contact Kris (801) 585-3440.